Humanigen, Inc. announced that on July 18, 2023, John Hohneker resigned from the Board, and on July 19, 2023 Cheryl Buxton and Kevin Xie both resigned from the Board, in each case with immediate effect. The decisions of Dr. Hohneker, Ms. Buxton and Mr. Xie to resign were not the result of disagreements with Humanigen on any matter relating to Humanigen's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | -33.33% | -83.33% |
04-12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
03-08 | Final DIP Financing Approved for Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-83.33% | 23.82K | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Board Changes